CONNELLY ROBERT (CEO, President and Director) received a stock award from ELICIO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/3/2026ACC: 0001601485-26-000010
DirectorOfficer· CEO, President and Director
Since Feb 2026
+220.80K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
220.80K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+73.60K
Price / share
—
Trade value
—
% of position
156.7%
2/2/2026
46.97K→120.57K
Total
Net shares
+73.60K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | A · Award | +73.60K | — | — | 156.7% | 46.97K | 120.57K |
| Total | +73.60K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
147.20K shares
Shares
+147.20K
Strike price
8.10
Held after
147.20K
Exercisable
—
2/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock147.20K shares | 2/2/2026 | A · Award | +147.20K | 8.10 | — | 147.20K |